Persons taking select Type 2 diabetes drugs were exposed to a risk for a rare, life-threatening genital infection known as necrotizing fasciitis or Fournier's gangrene. Following an FDA drug safety warning, four drug manufacturers of thirteen different SGLT2 inhibiting diabetes drugs have been forced to add a diabetes drug infection warning to their products' labels. Pharmaceutical executives argue the benefits of these popular medications outweigh the risks; safety advocates point out the existence of alternatives that do not cause flesh-eating genital infections. The market for SGLT2 inhibiting diabetes drugs is expected to reach $7 billion by 2020, and each of the companies in question is vying to dominate this lucrative market.
Persons who developed a severe genital infection while taking one of the diabetes drugs in question are seeking clarification on the qualifications required to participate in a diabetes drug infection lawsuit. Our law firm offers free, no-obligation, confidential consultations to anyone who feels they may have a claim, but we have outlined the basic qualifications in this section. In general, these are factors that are considered in each diabetes genital infection lawsuit claim.
For persons and family members of persons who meet these qualifications, it is likely you will be eligible to file a diabetes drug claim for genital infection. There are multiple reasons to file a claim. First, diabetes infection lawyers believe individuals who have suffered from necrotizing fasciitis may be eligible for compensation for the expense of medical treatment, pain, suffering, and loss associated with diabetes drug infections. More meaningful to some is an opportunity to hold multinational pharmaceutical corporations accountable for patient safety and dishonest business practices. Sometimes the only means to force a company to become a better corporate citizen is through the threat of litigation.